Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

Author： Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.14, 2000-09, pp. : 1773-1780

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study

By Catalano Vincenzo   Vincenzi Bruno   Giordani Paolo   Graziano Francesco   Santini Daniele   Baldelli Anna   Alessandroni Paolo   Schiavon Gaia   Rossi David   Casadei Virginia   D’Emidio Silvia   Luzi Fedeli Stefano   Tonini Giuseppe   Fiorentini Giammaria  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 419-426

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group

By Masuda Norikazu   Taguchi Tetsuya   Nakayama Takahiro   Shiba Eiichi   Watatani Masahiro   Kurebayashi Junichi   Takatsuka Yuichi   Sakamoto Junichi   Noguchi Shinzaburo  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 989-995

Springer Publishing Company

Access to resources Recommend Favorite

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite

Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study

By Bonneterre J.   Campone M.   Koralewski P.   Blasinska-Morawiec M.   Deporte-Fety R.   Chatelut E.   Leger F.   Longerey B.   Ecochard L.   Douville I.  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 365-373

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group - a nonrandomized pilo

By Sjostrom J.   Blomqvist C.   Mouridsen H.   Pluzanska A.   Ottosson-Lonn S.   Bengtsson N.-O.   Ostenstad B.   Mjaaland I.   Palm-Sjovall M.   Wist E.   Valvere V.   Anderson H.   Bergh J.  

European Journal of Cancer, Vol. 35, Iss. 8, 1999-08 ,pp. : 1194-1201

Elsevier

Access to resources Recommend Favorite